I am immensely happy to connect with you through this September 2014 edition of Oviya MedSafe’s newsletter, which will not only update you about our organization but also provide you with useful insights on the recent advancements made in the domain of pharmacovigilance across the world, especially in India.
As you know, Oviya MedSafe (in association with UK-based Assured Information Systems) organized a free webinar titled ‘Assuring Cost-Effective Global Pharmacovigilance Compliance’ for pharmaceutical companies on 10-Sep-2014, which session included a complimentary demonstration of Assured Information Systems’ human pharmacovigilance hosted software database PV247. The patronage for the webinar & demo session far exceeded our expectations and helped us realize that what we already offer at the moment is exactly the pharmacovigilance package that pharmaceutical companies would dream of, for the future: a comprehensive, reliable, economical, E2B & 21 CFR Part 11 compliant, user-friendly and global solution.
It is my duty to thank leading pharmaceutical industry magazines Express Pharma and Pharmabiz for featuring the news about the event and our partnership for PV247 respectively. With our inboxes being filled with appreciations and requests for more information, we have begun to think that we should run such sessions periodically on a regular basis, for the benefit of those who missed our first event. I take this opportunity to thank all the attendees of the webinar & demo and look forward to your comments on it.
All the above developments indicate that pharmacovigilance regulations specific for India (especially for marketed products) need to be drafted and enforced at the earliest in order for pharmaceutical companies operating in India to ensure compliance with the regulatory requirements in India which would also help them remain compliant with the regulations in the other markets in which they are present. This is probably the time for all the stakeholders of Indian pharmacovigilance to come together under a common forum and resolve these larger issues amicably.
Before I conclude, I am glad to share with you the news about two conferences in which I will be speaking. The conferences organized by the OMICS group are co-located and will be conducted between 27-Oct-2014 and 29-Oct-2014 at Hyderabad International Convention Centre, Hyderabad, India.
Looking forward to meeting you all in October 2014 with news of further interest,
With thanks & regards,
Dr J Vijay Venkatraman
MBBS, F. Diab., MBA
Managing Director & CEO,
Pharmacovigilance Consulting & Drug Safety Services
Coimbatore, India & London, UK
India Office: +91-422-2444442
UK Office: +44-8452-733839